|
|
NPI Detail
NPI: 1154317527
Type: Organization
Taxonomy Code: 282N00000X
Hospital-General
Hospitals/General Acute Care Hospital
2500 X XXXXX XX
JACKSON, MS 39216
Business phone: (XXX) XXX-XXXX
Mailing address phone: (XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1154317527*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
| Procedure | Description | Number Submitted | Medicare Payment |
| 36415
|
ROUTINE VENIPUNCTURE
|
XXXXX
|
$XXXXX.XX
|
| 85025
|
COMPLETE CBC W/AUTO DIFF WBC
|
XXXXX
|
$XXXXX.XX
|
| 80053
|
COMPREHEN METABOLIC PANEL
|
XXXXX
|
$XXXXX.XX
|
| 97110
|
THERAPEUTIC EXERCISES
|
XXXXX
|
$XXXXXX.XX
|
Top Drugs Administered Other than Oral Method
| Procedure | Description | Number Submitted | Medicare Payment |
| J0897
|
Denosumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J0585
|
Injection,onabotulinumtoxina
|
XXXXX
|
$XXXXXX.XX
|
| J9267
|
Paclitaxel injection
|
XXXXX
|
-
|
| J1439
|
Inj ferric carboxymaltos 1mg
|
XXXXX
|
$XXXXX.XX
|
| J9299
|
Injection, nivolumab
|
XXXXX
|
$XXXXXX.XX
|
| J1453
|
Fosaprepitant injection
|
XXXXX
|
$XXXX.XX
|
| J9271
|
Inj pembrolizumab
|
XXXXX
|
$XXXXXXX.XX
|
| J2405
|
Ondansetron hcl injection
|
XXXXX
|
-
|
| J2323
|
Natalizumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J1756
|
Iron sucrose injection
|
XXXXX
|
-
|
| J9025
|
Azacitidine injection
|
XXXXX
|
$XXXXX.XX
|
| J9306
|
Injection, pertuzumab, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J1100
|
Dexamethasone sodium phos
|
XXXXX
|
-
|
| J0881
|
Darbepoetin alfa, non-esrd
|
XXXXX
|
$XXXXX.XX
|
| J9144
|
Daratumumab, hyaluronidase
|
XXXXX
|
$XXXXXX.XX
|
| J9264
|
Paclitaxel protein bound
|
XXXXX
|
$XXXXXX.XX
|
| J3262
|
Tocilizumab injection
|
XXXXX
|
$XXXXX.XX
|
| J1447
|
Inj tbo filgrastim 1 microg
|
XXXXX
|
$XXXX.XX
|
| J7168
|
Prothrombin complex kcentra
|
XXXXX
|
$XXXXX.XX
|
| J9041
|
Injection, bortezomib, 0.1mg
|
XXXXX
|
$XXXXXX.XX
|
| J1300
|
Eculizumab injection
|
XXXXX
|
$XXXXXXX.XX
|
| J2350
|
Injection, ocrelizumab, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J1561
|
Gamunex-c/gammaked
|
XXXXX
|
$XXXXXX.XX
|
| J3380
|
Injection, vedolizumab
|
XXXXX
|
$XXXXXX.XX
|
| J1602
|
Golimumab for iv use 1mg
|
XXXXX
|
$XXXXXX.XX
|
| J1459
|
Inj ivig privigen 500 mg
|
XXXXX
|
$XXXXXX.XX
|
| J9263
|
Oxaliplatin
|
XXXXX
|
-
|
| J0256
|
Alpha 1 proteinase inhibitor
|
XXXXX
|
$XXXXX.XX
|
| J0896
|
Inj luspatercept-aamt 0.25mg
|
XXXXX
|
$XXXXXX.XX
|
| J1745
|
Infliximab not biosimil 10mg
|
XXXXX
|
$XXXXXX.XX
|
Top HCPC Level II Procedures / Professional Services
| Procedure | Description | Number Submitted | Medicare Payment |
| G0378
|
Hospital observation per hr
|
XXXXX
|
-
|
| G0463
|
Hospital outpt clinic visit
|
XXXXX
|
$XXXXXX.XX
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|
